Summit Therapeutics Inc. (NASDAQ:SMMT) stock is trading lower on Monday. The company shared progress on its lead drug candidate and third-quarter financial results. On Sunday, Summit Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback